Exopharm Limited (EX1.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
At close: 04:57PM AEDT
| Previous close | 0.1350 |
| Open | 0.1350 |
| Bid | 0.1400 x 250000 |
| Ask | 0.1500 x 1097400 |
| Day's range | 0.1350 - 0.1500 |
| 52-week range | 0.1100 - 0.5900 |
| Volume | |
| Avg. volume | 55,827 |
| Market cap | 21.224M |
| Beta (5Y monthly) | 1.51 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0670 |
| Earnings date | 30 Aug 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Exopharm Limited (ASX:EX1) up 14%, but insiders are still down 49% after purchasing AU$895k of stock last year
Some of the losses seen by insiders who purchased AU$895k worth of Exopharm Limited ( ASX:EX1 ) shares over the past...
- Simply Wall St.
Is Exopharm (ASX:EX1) In A Good Position To Deliver On Growth Plans?
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
- PR Newswire
Exopharm and Astellas Institute for Regenerative Medicine (AIRM) Sign Master Collaborative Services Agreement
Exopharm Limited (ASX:EX1) has signed a Master Collaborative Services Agreement (MSA) with the Astellas Institute for Regenerative Medicine (AIRM).
© 2022 Yahoo. All rights reserved.
